Sustained-Release L-DOPA for Parkinson’s Disease

Novel Analgesic Target for Chronic Pain

New treatment approach for pain of unknown cause

Therapeutic Target and Drug for Spinal and Bulbar Muscular Atrophy (SBMA)

Inhibitors against a new therapeutic target molecule improved the body weight, grip power, performance on the rotarod task and lifespan of SBMA mouse model.

HPGCD for Niemann-Pick Type C (NPC) Therapy without Side Effects

Intrathecal HPGCD(2-Hydroxypropyl-γ-cyclodextrin) improving brain abnormalities in NPC patients without side effects

Neprilysin-targeted Therapy for Alzheimer’s Disease

Small molecule therapy through enhancement of neprilysin activity.